Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 359


Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).

Urbanic JJ, Wang X, Bogart JA, Stinchcombe TE, Hodgson L, Schild SE, Bazhenova L, Hahn O, Salgia R, Vokes EE.

Int J Radiat Oncol Biol Phys. 2018 Jan 31. pii: S0360-3016(18)30109-3. doi: 10.1016/j.ijrobp.2018.01.046. [Epub ahead of print]


The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.

Salgia R, Kulkarni P.

Trends Cancer. 2018 Feb;4(2):110-118. doi: 10.1016/j.trecan.2018.01.001. Epub 2018 Feb 3. Review.


The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer.

Amanam I, Gupta R, Mambetsariev I, Salgia R.

Future Oncol. 2018 Feb 16. doi: 10.2217/fon-2017-0545. [Epub ahead of print]


EphB4: A promising target for upper aerodigestive malignancies.

Salgia R, Kulkarni P, Gill PS.

Biochim Biophys Acta. 2018 Jan 30;1869(2):128-137. doi: 10.1016/j.bbcan.2018.01.003. [Epub ahead of print] Review.


Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.

Gong J, Chehrazi-Raffle A, Reddi S, Salgia R.

J Immunother Cancer. 2018 Jan 23;6(1):8. doi: 10.1186/s40425-018-0316-z. Review.


Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.

Kanteti R, Mirzapoiazova T, Riehm JJ, Dhanasingh I, Mambetsariev B, Wang J, Kulkarni P, Kaushik G, Seshacharyulu P, Ponnusamy MP, Kindler HL, Nasser MW, Batra SK, Salgia R.

Cancer Biol Ther. 2018 Jan 5:1-12. doi: 10.1080/15384047.2017.1416937. [Epub ahead of print]


Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States.

Jinjuvadia R, Salami A, Lenhart A, Jinjuvadia K, Liangpunsakul S, Salgia R.

Am J Med Sci. 2017 Oct;354(4):362-369. doi: 10.1016/j.amjms.2017.05.016. Epub 2017 Jun 1.


State-of-the-art considerations in small cell lung cancer brain metastases.

Lukas RV, Gondi V, Kamson DO, Kumthekar P, Salgia R.

Oncotarget. 2017 Jul 18;8(41):71223-71233. doi: 10.18632/oncotarget.19333. eCollection 2017 Sep 19. Review.


Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.

Bhanot H, Weisberg EL, Reddy MM, Nonami A, Neuberg D, Stone RM, Podar K, Salgia R, Griffin JD, Sattler M.

Oncotarget. 2017 Jun 28;8(40):67639-67650. doi: 10.18632/oncotarget.18797. eCollection 2017 Sep 15.


Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience.

Yuan Y, Yost SE, Yim J, Yuan YC, Solomon NM, Mambetsariev I, Pal S, Frankel P, Salgia R, Neuhausen SL, Mortimer J.

Oncotarget. 2017 Sep 22;8(37):62817. doi: 10.18632/oncotarget.20632. eCollection 2017 Sep 22.


A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

Reynolds KL, Bedard PL, Lee SH, Lin CC, Tabernero J, Alsina M, Cohen E, Baselga J, Blumenschein G Jr, Graham DM, Garrido-Laguna I, Juric D, Sharma S, Salgia R, Seroutou A, Tian X, Fernandez R, Morozov A, Sheng Q, Ramkumar T, Zubel A, Bang YJ.

BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6.


Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.

Tan YC, Mirzapoiazova T, Won BM, Zhu L, Srivastava MK, Vokes EE, Husain AN, Batra SK, Sharma S, Salgia R.

Sci Rep. 2017 Aug 23;7(1):9192. doi: 10.1038/s41598-017-09078-4.


Outcome of liver transplantation in patients with prior bariatric surgery.

Safwan M, Collins KM, Abouljoud MS, Salgia R.

Liver Transpl. 2017 Nov;23(11):1415-1421. doi: 10.1002/lt.24832.


Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention.

Reb A, Ruel N, Fakih M, Lai L, Salgia R, Ferrell B, Sampath S, Kim JY, Raz DJ, Sun V.

Eur J Oncol Nurs. 2017 Aug;29:125-134. doi: 10.1016/j.ejon.2017.06.003. Epub 2017 Jun 19.


Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.

Wood K, Byron E, Janisch L, Salgia R, Sharma MR.

Am J Clin Oncol. 2017 Jun 26. doi: 10.1097/COC.0000000000000400. [Epub ahead of print]


Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.

Jen J, Lin LL, Lo FY, Chen HT, Liao SY, Tang YA, Su WC, Salgia R, Hsu CL, Huang HC, Juan HF, Wang YC.

Oncogene. 2017 Sep 7;36(36):5219. doi: 10.1038/onc.2017.203. Epub 2017 Jun 19.


Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.

Little EC, Kubic JD, Salgia R, Grippo PJ, Lang D.

Oncol Lett. 2017 Jun;13(6):4027-4034. doi: 10.3892/ol.2017.5956. Epub 2017 Mar 29.


Value-Based Medicine and Integration of Tumor Biology.

Brooks GA, Bosserman LD, Mambetsariev I, Salgia R.

Am Soc Clin Oncol Educ Book. 2017;37:833-840. doi: 10.14694/EDBK_175519. Review.


Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.

Zhang K, Wang J, Tong TR, Wu X, Nelson R, Yuan YC, Reno T, Liu Z, Yun X, Kim JY, Salgia R, Raz DJ.

Int J Cancer. 2017 Aug 15;141(4):766-777. doi: 10.1002/ijc.30769. Epub 2017 May 31.


The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.

Mok TSK, Crino L, Felip E, Salgia R, De Pas T, Tan DSW, Chow LQM.

Cancer Treat Rev. 2017 Apr;55:181-189. doi: 10.1016/j.ctrv.2017.03.006. Epub 2017 Mar 30. Review.

Supplemental Content

Loading ...
Support Center